Health is a unity and harmony within the mind, body and spirit which is unique to each person, and is as defined by that person. The level of wellness or health is, in part, determined by the ability to deal with and defend against stress. Health is determined by physiological, psychological, socio-cultural, spiritual, and developmental stage variables.

Withdrawn MS drug returns to market

Multiple Sclerosis :: Withdrawn MS drug returns to market

Just months after receiving FDA approval, natalizumab, a medication for the treatment of multiple sclerosis (MS) and other inflammatory disorders, was voluntarily withdrawn by its manufacturers after three patients developed a brain infection known as Progressive Multifocal Leukoencephalopathy (PML).

Natalizumab has recently been re-approved by the FDA, and a comprehensive article published in the latest issue of CNS Drug Reviews provides a timely overview of the drug, its pharmacological properties, clinical efficacy, safety and toxicology.

MS is a disorder that affects the central nervous system, with leukocytes (inflammatory cells) attacking the body?s neurons and causing serious damage. A highly effective immunosuppressive treatment, natalizumab is an antibody that prevents leukocytes from crossing blood vessel walls into tissues such as the brain and spinal cord. The drug may also benefit secondary lymphoid organs, such as lymph nodes and the spleen, and inhibit reactivation in the central nervous system. It has been shown to significantly reduce leukocyte cell numbers in spinal fluid, with benefits continuing for six months after treatment.

"The release of natalizumab ushers in a new era in the treatment of MS," says Dr. Olaf St?ve , author of the study, noting, however, that while the short-term risk-benefit ratio appears positive, the long-term risks remain unknown. "As therapy with natalizumab resumes worldwide, the neurologic community will garner more information about the long-term risks and benefits of this powerful therapeutic medication," but for now natalizumab use is being strictly monitored. Both the FDA and TOUCH, a special distribution program designed to prevent patients not qualified for the treatment from receiving the drug, are working to make sure that any potential infectious complications are identified as early as possible.

Recently posted related articles on Multiple Sclerosis :

1. Multiple Sclerosis :: Jefferson neuroscientists show anti-inflammation molecule helps fight MS-like disease
2. Multiple Sclerosis :: MS that runs in families appears more severe than non-familial MS
3. Multiple Sclerosis :: Accentia announces investigational new drug application for Revimmune for refractory MS
4. Multiple Sclerosis :: Antibody leads to repair of myelin sheath in lab study of multiple sclerosis and related disorders
5. Smoking :: Smoking has no effect on progression of multiple sclerosis
6. Multiple Sclerosis :: Patients own stem cells injected to treat multiple sclerosis
7. Multiple Sclerosis :: Cell-surface sugar defects may trigger nerve damage in multiple sclerosis patients
8. Multiple Sclerosis :: Waddell Center Experts Conduct Multiple Sclerosis Symposium
9. MRI :: New MRI finding sheds light on multiple sclerosis disease progression
10. Multiple Sclerosis :: Fish oil might help multiple sclerosis patients